Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Clinical trial NCT04902833 · COMPLETED

Trial details

NCT number: NCT04902833
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Pyruvate Kinase Deficiency Pyruvate Kinase Deficiency Anemia Hereditary Hemolytic Anemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm Clonal Myeloid Neoplasm Myeloproliferative Neoplasm Acute Myeloid Leukemia Clonal Cytopenia of Undetermined Significance Other Clonal Myeloid Neoplasm Unexplained Coombs-negative Non-immune Hemolytic Anemia

Start date: 2022-02-01
Primary completion: 2026-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.